Everyday Health on MSN
We tested over 50 pairs of walking shoes for women — these are the 13 we recommend
We tested walking shoes and spoke to podiatrists to find the 13 best for women to fit any lifestyle or foot need.
Novo Nordisk fell about 2% on early Friday even after the U.S. Food and Drug Administration approved a higher-dose version of its obesity ...
If adolescents replaced 30 minutes of sedentary time each day with sleep or moderate-to-vigorous physical activity, it may ...
A sweeping review of decades of research is challenging a long-standing claim in food policy debates: that federal nutrition assistance programs contribute to childhood obesity. Researchers at the ...
In a new clinical practice guideline, recommendations are presented for the diagnosis and management of faltering weight in young pediatric patients.
Investor's Business Daily on MSN
Rhythm surges on a new obesity approval; how it edged in where Lilly, Novo 'have fallen flat'
Rhythm Pharmaceuticals stock popped Friday after the FDA signed off on its obesity drug for patients with a rare, hunger-spiking disease.
Currently on a Mounjaro injectable, he wants to get rid of it some day and doesn’t want it to define his life. “It got me off a dangerous ledge called obesity, made me confident, made me do things ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results